购物车
- 全部删除
- 您的购物车当前为空
Hsp110/sGC-modulator-1 (compound 17i) 是一种双靶点调节剂,可口服活性以针对 Hsp110 和 sGC,展现出优异的分子活性.该化合物不仅能显著抑制细胞的恶性表型,还具有血管扩张功能.此外,Hsp110/sGC-modulator-1 (compound 17i) 亦能通过抑制 Hsp110 减轻肺血管重构和右心室肥厚的病理状态.
Hsp110/sGC-modulator-1 (compound 17i) 是一种双靶点调节剂,可口服活性以针对 Hsp110 和 sGC,展现出优异的分子活性.该化合物不仅能显著抑制细胞的恶性表型,还具有血管扩张功能.此外,Hsp110/sGC-modulator-1 (compound 17i) 亦能通过抑制 Hsp110 减轻肺血管重构和右心室肥厚的病理状态.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | Hsp110/sGC-modulator-1 (compound 17i) is a dual-target modulator of Hsp110 and sGC with oral activity, exhibiting optimal molecular activity against both Hsp110 and sGC targets. Additionally, it demonstrates significant inhibitory effects on malignant cellular phenotypes and vasodilation. Hsp110/sGC-modulator-1 (compound 17i) alleviates pulmonary vascular remodeling and right ventricular hypertrophy by inhibiting Hsp110. |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容